Marcelo Almeida Nakashima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Marcelo Almeida Nakashima has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Carlos Renato Tirapelli
Universidade de São Paulo
2 shared publications Janaina A. Simplicio
Escola de Enfermagem de Ribeirão Preto, DEPCH, Universidade de São Paulo (USP), Ribeirão Preto, SP, Brazil; Faculdade de Medicina de Ribeirão Preto, USP, Ribeirão Preto, SP, Brazil
2 shared publications- Ana Carolina Mieko Omoto
University of Mississippi Medical Center
1 shared publication - Bruno Spinosa De Martinis
Universidade de São Paulo
1 shared publication - Carla Brigagão Pacheco da Silva
Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo
1 shared publication - Daniel Fernandes
Universidade Federal de Santa Catarina/ Departamento de Farmacologia
1 shared publication
Latest Publications
- Open Access
- 28 February 2025
- Published by The Korean Society of Critical Care Medicine in Acute and Critical Care
- Vol. 40 (1) , 46-58
Impact of tadalafil on cardiovascular and organ dysfunction induced by experimental sepsis
Background: Sepsis is a life-threatening condition that affects the cardiovascular and renal systems. Severe hypotension during sepsis compromises tissue perfusion, which can lead to multiple organ dysfunction and death. Phosphodiesterase 5 (PDE5) degrades intracellular cyclic guanosine monophosphate (cGMP) levels which promotes vasodilatation in specific sites. Our previous studies show that inhibiting cGMP production in early sepsis increases mortality, implying a protective role for cGMP production. Then, we hypothesized that cGMP increased by tadalafil (PDE5 inhibitor) could improve microcirculation and prevent sepsis-induced organ dysfunction.Methods: Rats were submitted to cecal ligation and puncture (CLP) sepsis model and treated with tadalafil (2 mg/kg, s.c.) 8 hours after the procedure. Hemodynamic, inflammatory and biochemical assessments were performed 24 hours after sepsis induction. Moreover, the effect of tadalafil on the survival of septic rats was evaluated for 5 days.Results: Tadalafil treatment improves basal renal blood flow during sepsis and preserves it during noradrenaline infusion. Sepsis induces hypotension, impaired response to noradrenaline, and increased cardiac and renal neutrophil infiltration, in addition to increased levels of plasma nitric oxide and lactate. None of these dysfunctions were changed by tadalafil. Additionally, tadalafil treatment did not increase the survival rate of septic rats.Conclusions: Tadalafil improved microcirculation of septic animals; however, no beneficial effects were observed on macrocirculation and inflammation parameters. Then, the potential benefit of tadalafil in the prognosis of sepsis should be evaluated within a therapeutic strategy covering all sepsis injury mechanisms.
- 28 February 2025
- Published by The Korean Society of Critical Care Medicine in Acute and Critical Care
- Vol. 40 (1) , 46-58
Open AccessImpact of tadalafil on cardiovascular and organ dysfunction induced by experimental sepsis
Background: Sepsis is a life-threatening condition that affects the cardiovascular and renal systems. Severe hypotension during sepsis compromises tissue perfusion, which can lead to multiple organ dysfunction and death. Phosphodiesterase 5 (PDE5) degrades intracellular cyclic guanosine monophosphate (cGMP) levels which promotes vasodilatation in specific sites. Our previous studies show that inhibiting cGMP production in early sepsis increases mortality, implying a protective role for cGMP production. Then, we hypothesized that cGMP increased by tadalafil (PDE5 inhibitor) could improve microcirculation and prevent sepsis-induced organ dysfunction.Methods: Rats were submitted to cecal ligation and puncture (CLP) sepsis model and treated with tadalafil (2 mg/kg, s.c.) 8 hours after the procedure. Hemodynamic, inflammatory and biochemical assessments were performed 24 hours after sepsis induction. Moreover, the effect of tadalafil on the survival of septic rats was evaluated for 5 days.Results: Tadalafil treatment improves basal renal blood flow during sepsis and preserves it during noradrenaline infusion. Sepsis induces hypotension, impaired response to noradrenaline, and increased cardiac and renal neutrophil infiltration, in addition to increased levels of plasma nitric oxide and lactate. None of these dysfunctions were changed by tadalafil. Additionally, tadalafil treatment did not increase the survival rate of septic rats.Conclusions: Tadalafil improved microcirculation of septic animals; however, no beneficial effects were observed on macrocirculation and inflammation parameters. Then, the potential benefit of tadalafil in the prognosis of sepsis should be evaluated within a therapeutic strategy covering all sepsis injury mechanisms.
- 1 October 2017
- Published by Elsevier in Journal of the American Society of Hypertension
- Vol. 11 (10) , 684-696.e3
Tumor necrosis factor-α receptor 1 contributes to ethanol-induced vascular reactive oxygen species generation and hypertension
- 1 October 2017
- Published by Elsevier in Journal of the American Society of Hypertension
- Vol. 11 (10) , 684-696.e3
Tumor necrosis factor-α receptor 1 contributes to ethanol-induced vascular reactive oxygen species generation and hypertension